New Tool: ProSource
Check out our packaging and processing solutions finder, ProSource.

Incorrect Label Potency Leads to Thyroid Drug Recall

Acella Pharmaceuticals has recalled its thyroid medication for the third time in a year over potency issues.

A recent WebMD article discussed a nationwide thyroid drug recall linked to incorrect information on the label. The drug in question is Acella Pharmaceuticals’ NP Thyroid medication intended to treat hypothyroidism. During routine testing, the affected lots were found to contain less than 90% of the two ingredients listed on the label: liothyronine and levothyroxine.

At least 43 adverse events have been reported in relation to the drug, which could be linked to the recall. This is the third recall related to this particular drug’s potency in the past year. Back in November, the potency was too low, and last May it was overly potent. 

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts